Drug to treat a particular form of muscular dystrophy approved in Europe. Approval granted under a special measure that allows drugs to be offered when there is no other treatment option for a life-threatening illness.
Drug to treat a particular form of muscular dystrophy approved in Europe. Approval granted under a special measure that allows drugs to be offered when there is no other treatment option for a life-threatening illness.